A diabetes, heart failure, and kidney disease medication is the first of its kind to significantly reduce both heart attacks and strokes Post author:Annie Holland Post published:February 18, 2025 Post category:News Feed Post comments:0 Comments New research shows sotagliflozin is the only drug in its class to demonstrate these results. You Might Also Like Starving cancer cells of fat may improve cancer treatment October 23, 2024 Shining a light on the hidden damage of mild brain injuries January 4, 2024 Large-scale study of children with genetic disorders finds huge benefit of diagnosis October 16, 2024 Leave a Reply Cancel replyCommentEnter your name or username to comment Enter your email address to comment Enter your website URL (optional) Save my name, email, and website in this browser for the next time I comment.
Large-scale study of children with genetic disorders finds huge benefit of diagnosis October 16, 2024